Emmessar Biotech & Nutrition share news and announcements
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹22.32.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹11 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Aug 2026
- 26.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Aug 2026
- −18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,899
Emmessar Biotech & Nutrition share news and announcements
536 announcements, routine notices left out, newest first. Page 7 of 11.
Sep 2018
Aug 2018
Jul 2018
9 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 7 7 06 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
Jun 2018
May 2018
3 May · Board Meeting - Board Meeting On May 16, 2018
Apr 2018
19 Apr · Compliances - Compliance Certificate For The Period Ended March 2018
10 Apr · Compliance - U/R 40(9) Of SEBI LODR Regulations, 2015
10 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....5 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 5 5 0
Mar 2018
Feb 2018
Jan 2018
15 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....12 Jan · Statement Of Investor Complaint For The Quarter Ended December 31, 2017
Nov 2017
Oct 2017
30 Oct · Legal
30 Oct · Legal
Exchange has sought clarification from Emmessar Biotech & Nutrition Ltd on October 30, 2017 , with reference to increase in Price. The reply is awaited.10 Oct · Statement Of Investors Complaint For The Quarter Ended 30-09-2017
10 Oct · Filing Of Compliance Certificate Under Regln. 7(3) For The Half Year Ended September 30, 2017
9 Oct · Compliance Certificate Under Regulation 40(9)Of SEBI [LODR} Reglns, 2015
5 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
Sep 2017
4 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2017
24 Aug · Reconciliation Statement For Quarter End June 2017
24 Aug · Reconciliation Statement For Quarter End June 2017
Jul 2017